News
DMIIU
10.16
+0.05%
0.01
Drugs Made in America Acquisition II Corp. Begins Separate Trading of Shares and Rights
Reuters · 12/03/2025 11:34
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Barchart · 12/03/2025 05:34
*News On Drugs Made In America Acquisition II Corp. (DMIIU) Now Under DMII
Dow Jones · 12/02/2025 22:09
Drugs Made in America Acquisition II Corp. Delays Quarterly Report Filing
Reuters · 11/17/2025 11:30
Audit Report Released for Drugs Made in America Acquisition II Corp.’s Financial Statements
Reuters · 10/02/2025 21:15
Drugs Made In America Acquisition II LLC Reports Disposal of Common Shares of Drugs Made in America Acquisition II Corp
Reuters · 10/01/2025 14:38
Drugs Made In America Acquisition II Corp. Launches $500 Million IPO, Begins Trading on Nasdaq Under Ticker "DMIIU
Reuters · 09/29/2025 21:29
U.S. IPO Weekly Recap: One Small Debut As More Names Join The Pipeline
Seeking Alpha · 09/27/2025 04:30
DRUGS MADE IN AMERICA ACQUISITION II CORP. ANNOUNCES CLOSING OF $500,000,000 INITIAL PUBLIC OFFERING
Reuters · 09/26/2025 20:05
*Drugs Made in America Acquisition II Announces Pricing of $500M Initial Public Offering
Dow Jones · 09/25/2025 10:48
More
Webull provides a variety of real-time DMIIU stock news. You can receive the latest news about Drugs Made In America Acquisition II Corp. through multiple platforms. This information may help you make smarter investment decisions.
About DMIIU
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenue to date.